Business of Healthcare Innovation & Technology

Community Care of North Carolina Chooses Bamboo Health to Improve Care Coordination and Patient Outcomes

ByDennis Dailey February 9, 2022March 3, 2026

Marketing

Highmark Health Expands Access to Freespira’s Digital Therapeutic Treatment for Panic Attacks, Panic Disorder and PTSD

Read More Highmark Health Expands Access to Freespira’s Digital Therapeutic Treatment for Panic Attacks, Panic Disorder and PTSD
Awards and Recognition Business of Healthcare M&A and Finance Research Voices & Perspectives

AION Labs, In Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations

Read More AION Labs, In Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations
Digital Health Research

New Research Shows Connect America’s Personal Emergency Response Services (PERS) with CareSage Analytics Prevent Unnecessary Care Utilization, ED Visits, and Hospital Readmissions Among Seniors

Connect America Home platform data and recent Institutional Review Board (IRB)-approved study confirms that its PERS with CareSage analytics…

Read More New Research Shows Connect America’s Personal Emergency Response Services (PERS) with CareSage Analytics Prevent Unnecessary Care Utilization, ED Visits, and Hospital Readmissions Among Seniors
Business of Healthcare Devices Innovation & Technology M&A and Finance

Casana Closes $30 Million Series B Funding to Accelerate Development of Novel Effortless Home Health Monitoring

The Heart Seat, an effortless, patient-centered health monitoring technology built into a toilet seat, is Casana’s first product…

Read More Casana Closes $30 Million Series B Funding to Accelerate Development of Novel Effortless Home Health Monitoring
M&A and Finance Research

Append Medical Completes $7.4M Million Series A Round

Funding Will Support the Company’s First Clinical Trial on its Path to Regulatory Clearance Append Medical, developer of the…

Read More Append Medical Completes $7.4M Million Series A Round
People

Dance Biopharm Strengthens Leadership Team to Advance Late-Stage Diabetes Development Program and Transition Pipeline Candidates into Clinical Trials

Dance Biopharm Holdings Inc. (“the Company” or “Dance”), a privately-held clinical stage biopharma company focused on the development of novel…

Read More Dance Biopharm Strengthens Leadership Team to Advance Late-Stage Diabetes Development Program and Transition Pipeline Candidates into Clinical Trials

Similar Posts